PROS1 and COVID-19: However, the reduced PROS1, which is the preferred activating ligand for MerTK (44, 48), and the fewer homeostatic resident AMs in severe COVID-19 might enable unrestricted proinflammatory cytokine production by locally differentiated MerTK-expressing FCN+ and FCN+SPP1+ macrophages.